 Michael Chen
Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 18 | 2018 | 305 | 4.370 |
Why?
| | Thrombectomy | 7 | 2018 | 39 | 2.690 |
Why?
| | Endovascular Procedures | 10 | 2018 | 59 | 2.440 |
Why?
| | Intracranial Aneurysm | 5 | 2016 | 78 | 2.400 |
Why?
| | Brain Ischemia | 9 | 2018 | 82 | 2.210 |
Why?
| | Cerebral Angiography | 5 | 2016 | 59 | 2.180 |
Why?
| | Embolization, Therapeutic | 5 | 2014 | 71 | 1.860 |
Why?
| | Intracranial Hemorrhages | 4 | 2017 | 14 | 1.670 |
Why?
| | Arteriovenous Fistula | 3 | 2016 | 7 | 1.550 |
Why?
| | Thrombolytic Therapy | 6 | 2014 | 71 | 1.470 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2016 | 11 | 1.470 |
Why?
| | Aneurysm, Ruptured | 2 | 2016 | 25 | 1.410 |
Why?
| | Arterial Occlusive Diseases | 4 | 2017 | 17 | 1.190 |
Why?
| | Humans | 52 | 2018 | 25275 | 1.000 |
Why?
| | Cerebrovascular Disorders | 3 | 2015 | 78 | 0.930 |
Why?
| | Middle Aged | 24 | 2018 | 9439 | 0.870 |
Why?
| | Corneal Transplantation | 1 | 2017 | 1 | 0.860 |
Why?
| | Corneal Diseases | 1 | 2017 | 4 | 0.860 |
Why?
| | Retrospective Studies | 16 | 2018 | 2518 | 0.840 |
Why?
| | Social Class | 1 | 2017 | 54 | 0.820 |
Why?
| | Treatment Outcome | 11 | 2018 | 3134 | 0.810 |
Why?
| | Patient Transfer | 1 | 2017 | 22 | 0.810 |
Why?
| | Female | 30 | 2018 | 14955 | 0.800 |
Why?
| | Adult | 20 | 2018 | 8233 | 0.780 |
Why?
| | Stents | 4 | 2018 | 149 | 0.770 |
Why?
| | Aged | 21 | 2018 | 8370 | 0.750 |
Why?
| | Male | 33 | 2018 | 14662 | 0.720 |
Why?
| | Neurosurgery | 2 | 2015 | 37 | 0.720 |
Why?
| | Informed Consent | 1 | 2015 | 24 | 0.710 |
Why?
| | Periodicals as Topic | 2 | 2015 | 34 | 0.700 |
Why?
| | Mandible | 2 | 2018 | 15 | 0.700 |
Why?
| | Self-Help Groups | 1 | 2014 | 8 | 0.700 |
Why?
| | Outcome Assessment (Health Care) | 2 | 2014 | 279 | 0.700 |
Why?
| | Tomography, X-Ray Computed | 5 | 2014 | 781 | 0.690 |
Why?
| | Social Media | 1 | 2014 | 20 | 0.670 |
Why?
| | Vascular Access Devices | 1 | 2013 | 9 | 0.650 |
Why?
| | Maxilla | 1 | 2013 | 2 | 0.650 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2014 | 75 | 0.640 |
Why?
| | Cerebral Arteries | 1 | 2013 | 36 | 0.630 |
Why?
| | Adolescent | 8 | 2018 | 2270 | 0.590 |
Why?
| | Lasers, Excimer | 2 | 2009 | 2 | 0.580 |
Why?
| | Myopia | 2 | 2009 | 4 | 0.580 |
Why?
| | Keratomileusis, Laser In Situ | 2 | 2009 | 5 | 0.580 |
Why?
| | Aged, 80 and over | 13 | 2018 | 4259 | 0.560 |
Why?
| | Checklist | 1 | 2011 | 34 | 0.550 |
Why?
| | Tibia | 1 | 2013 | 208 | 0.540 |
Why?
| | Bone Transplantation | 1 | 2013 | 198 | 0.540 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2010 | 5 | 0.530 |
Why?
| | Intraoperative Complications | 1 | 2011 | 61 | 0.530 |
Why?
| | Estrogen Replacement Therapy | 1 | 2010 | 21 | 0.530 |
Why?
| | Device Removal | 1 | 2010 | 93 | 0.490 |
Why?
| | Corneal Dystrophies, Hereditary | 5 | 2010 | 6 | 0.490 |
Why?
| | Young Adult | 8 | 2018 | 1782 | 0.490 |
Why?
| | Cornea | 2 | 2008 | 8 | 0.490 |
Why?
| | Polycystic Kidney Diseases | 1 | 2009 | 4 | 0.480 |
Why?
| | Predictive Value of Tests | 3 | 2017 | 535 | 0.470 |
Why?
| | Connective Tissue Diseases | 1 | 2009 | 10 | 0.470 |
Why?
| | Migraine Disorders | 1 | 2009 | 19 | 0.470 |
Why?
| | Communicable Diseases | 1 | 2009 | 15 | 0.470 |
Why?
| | Follow-Up Studies | 8 | 2018 | 1745 | 0.440 |
Why?
| | Radiology, Interventional | 1 | 2008 | 5 | 0.440 |
Why?
| | Neuroradiography | 1 | 2008 | 3 | 0.440 |
Why?
| | Heart Defects, Congenital | 1 | 2009 | 49 | 0.430 |
Why?
| | Vascular Surgical Procedures | 1 | 2008 | 43 | 0.420 |
Why?
| | Mutation | 5 | 2010 | 410 | 0.410 |
Why?
| | Education, Medical, Graduate | 1 | 2008 | 65 | 0.400 |
Why?
| | Inflammation | 1 | 2009 | 284 | 0.390 |
Why?
| | Neurology | 1 | 2008 | 95 | 0.380 |
Why?
| | Biomechanical Phenomena | 1 | 2008 | 642 | 0.370 |
Why?
| | Morbidity | 2 | 2016 | 54 | 0.370 |
Why?
| | False Positive Reactions | 2 | 2017 | 36 | 0.370 |
Why?
| | Tissue Plasminogen Activator | 4 | 2015 | 69 | 0.360 |
Why?
| | Nanostructures | 1 | 2005 | 12 | 0.360 |
Why?
| | Adenoviridae | 1 | 2005 | 34 | 0.360 |
Why?
| | Prognosis | 4 | 2018 | 826 | 0.360 |
Why?
| | Genetic Vectors | 1 | 2005 | 65 | 0.350 |
Why?
| | Blood-Brain Barrier | 1 | 2005 | 41 | 0.350 |
Why?
| | Magnetic Resonance Angiography | 2 | 2016 | 46 | 0.340 |
Why?
| | Genetic Therapy | 1 | 2005 | 87 | 0.340 |
Why?
| | Aorta, Thoracic | 1 | 2004 | 15 | 0.330 |
Why?
| | Wounds, Nonpenetrating | 1 | 2004 | 19 | 0.330 |
Why?
| | Physical Exertion | 1 | 2002 | 9 | 0.300 |
Why?
| | Catheter Ablation | 2 | 2013 | 44 | 0.300 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 330 | 0.290 |
Why?
| | Kidney Neoplasms | 2 | 2013 | 103 | 0.280 |
Why?
| | Child | 4 | 2015 | 1315 | 0.270 |
Why?
| | Angiography, Digital Subtraction | 2 | 2016 | 12 | 0.230 |
Why?
| | Pelvic Neoplasms | 1 | 2018 | 3 | 0.230 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2018 | 8 | 0.230 |
Why?
| | Embolectomy | 2 | 2015 | 6 | 0.230 |
Why?
| | Prognathism | 1 | 2018 | 1 | 0.230 |
Why?
| | Cheek | 1 | 2018 | 2 | 0.230 |
Why?
| | Intraoperative Care | 1 | 2018 | 49 | 0.220 |
Why?
| | Clinical Trials as Topic | 3 | 2015 | 364 | 0.220 |
Why?
| | Radiotherapy, Intensity-Modulated | 2 | 2018 | 36 | 0.220 |
Why?
| | Fibrinolytic Agents | 3 | 2017 | 85 | 0.220 |
Why?
| | Proteins | 2 | 2009 | 87 | 0.220 |
Why?
| | Kenya | 1 | 2017 | 6 | 0.220 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2016 | 282 | 0.210 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 175 | 0.210 |
Why?
| | Societies, Medical | 2 | 2015 | 170 | 0.200 |
Why?
| | Evidence-Based Medicine | 2 | 2015 | 194 | 0.190 |
Why?
| | Rupture, Spontaneous | 1 | 2016 | 9 | 0.190 |
Why?
| | Subdural Effusion | 1 | 2015 | 7 | 0.190 |
Why?
| | Research Report | 1 | 2015 | 5 | 0.190 |
Why?
| | Hematoma, Subdural, Acute | 1 | 2015 | 12 | 0.180 |
Why?
| | Neurologic Examination | 1 | 2016 | 147 | 0.180 |
Why?
| | Extracellular Fluid | 1 | 2014 | 4 | 0.180 |
Why?
| | Writing | 1 | 2015 | 14 | 0.180 |
Why?
| | Research Personnel | 1 | 2015 | 19 | 0.170 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 21 | 0.170 |
Why?
| | Posterior Cerebral Artery | 1 | 2014 | 3 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2014 | 6 | 0.170 |
Why?
| | Cerebellar Neoplasms | 1 | 2014 | 7 | 0.170 |
Why?
| | Radiation Tolerance | 1 | 2014 | 9 | 0.170 |
Why?
| | Aneurysm | 1 | 2014 | 15 | 0.170 |
Why?
| | Databases, Factual | 1 | 2016 | 256 | 0.170 |
Why?
| | Hearing | 1 | 2014 | 15 | 0.170 |
Why?
| | Hearing Loss | 1 | 2014 | 19 | 0.170 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 43 | 0.170 |
Why?
| | tau Proteins | 1 | 2014 | 129 | 0.160 |
Why?
| | False Negative Reactions | 1 | 2013 | 16 | 0.160 |
Why?
| | Phobic Disorders | 1 | 2014 | 67 | 0.160 |
Why?
| | Brain Injuries | 1 | 2014 | 54 | 0.160 |
Why?
| | Taiwan | 1 | 2013 | 7 | 0.160 |
Why?
| | Neurofibrillary Tangles | 1 | 2014 | 152 | 0.160 |
Why?
| | Animals | 5 | 2014 | 4713 | 0.160 |
Why?
| | Biomedical Research | 1 | 2014 | 75 | 0.160 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 25 | 0.160 |
Why?
| | Magnetic Resonance Imaging, Interventional | 1 | 2013 | 8 | 0.160 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 49 | 0.160 |
Why?
| | Psychometrics | 1 | 2014 | 239 | 0.160 |
Why?
| | Genetic Linkage | 2 | 2010 | 43 | 0.160 |
Why?
| | Patient Selection | 2 | 2015 | 225 | 0.160 |
Why?
| | Neurosurgical Procedures | 1 | 2015 | 147 | 0.150 |
Why?
| | Depressive Disorder, Major | 1 | 2014 | 100 | 0.150 |
Why?
| | Open Reading Frames | 2 | 2010 | 16 | 0.150 |
Why?
| | Keratan Sulfate | 2 | 2010 | 29 | 0.150 |
Why?
| | Anxiety Disorders | 1 | 2014 | 174 | 0.150 |
Why?
| | Hospitalization | 1 | 2015 | 259 | 0.150 |
Why?
| | Refraction, Ocular | 2 | 2009 | 2 | 0.150 |
Why?
| | Pilot Projects | 1 | 2013 | 371 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 121 | 0.140 |
Why?
| | Angioplasty | 2 | 2010 | 14 | 0.140 |
Why?
| | Risk Factors | 2 | 2016 | 2162 | 0.140 |
Why?
| | Ductus Arteriosus | 1 | 2011 | 1 | 0.140 |
Why?
| | Extracellular Matrix Proteins | 2 | 2010 | 177 | 0.140 |
Why?
| | Fetal Diseases | 1 | 2011 | 10 | 0.140 |
Why?
| | Foramen Ovale, Patent | 1 | 2011 | 9 | 0.140 |
Why?
| | Heart Aneurysm | 1 | 2011 | 11 | 0.140 |
Why?
| | Injections, Intra-Arterial | 1 | 2011 | 15 | 0.140 |
Why?
| | Transportation of Patients | 1 | 2011 | 10 | 0.140 |
Why?
| | Kidney | 1 | 2013 | 174 | 0.130 |
Why?
| | Thromboembolism | 1 | 2011 | 35 | 0.130 |
Why?
| | Infarction, Middle Cerebral Artery | 1 | 2011 | 23 | 0.130 |
Why?
| | Suction | 1 | 2011 | 41 | 0.130 |
Why?
| | Antifibrinolytic Agents | 1 | 2011 | 14 | 0.130 |
Why?
| | Cross-Sectional Studies | 1 | 2013 | 739 | 0.130 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 46 | 0.130 |
Why?
| | Assisted Circulation | 1 | 2010 | 6 | 0.130 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2010 | 6 | 0.130 |
Why?
| | Chicago | 1 | 2013 | 768 | 0.130 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 176 | 0.130 |
Why?
| | Chondroitin Sulfate Proteoglycans | 1 | 2010 | 47 | 0.120 |
Why?
| | Hypothermia, Induced | 1 | 2010 | 23 | 0.120 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2009 | 2 | 0.120 |
Why?
| | Angioplasty, Balloon | 1 | 2009 | 25 | 0.120 |
Why?
| | Iris | 1 | 2009 | 4 | 0.120 |
Why?
| | Vasoconstriction | 1 | 2009 | 16 | 0.120 |
Why?
| | Visual Acuity | 1 | 2009 | 44 | 0.120 |
Why?
| | Corneal Stroma | 1 | 2009 | 1 | 0.120 |
Why?
| | Corneal Opacity | 1 | 2009 | 3 | 0.120 |
Why?
| | Paraproteinemias | 1 | 2009 | 4 | 0.120 |
Why?
| | Logistic Models | 1 | 2010 | 437 | 0.120 |
Why?
| | Corneal Topography | 1 | 2008 | 1 | 0.120 |
Why?
| | Intraocular Pressure | 1 | 2008 | 6 | 0.120 |
Why?
| | Radiography | 1 | 2011 | 672 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2010 | 579 | 0.110 |
Why?
| | Prospective Studies | 1 | 2013 | 1448 | 0.110 |
Why?
| | Hepatocyte Nuclear Factor 6 | 1 | 2008 | 1 | 0.110 |
Why?
| | Cholestasis, Extrahepatic | 1 | 2008 | 2 | 0.110 |
Why?
| | Human Growth Hormone | 1 | 2008 | 4 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2008 | 7 | 0.110 |
Why?
| | Intracranial Thrombosis | 1 | 2008 | 4 | 0.110 |
Why?
| | Surgical Flaps | 1 | 2008 | 56 | 0.110 |
Why?
| | Medicine | 1 | 2008 | 9 | 0.110 |
Why?
| | Infant | 2 | 2014 | 569 | 0.110 |
Why?
| | Specialization | 1 | 2008 | 13 | 0.110 |
Why?
| | Uniparental Disomy | 1 | 2007 | 1 | 0.110 |
Why?
| | Sulfotransferases | 1 | 2007 | 8 | 0.110 |
Why?
| | Age Factors | 1 | 2010 | 773 | 0.110 |
Why?
| | Education, Medical | 1 | 2008 | 36 | 0.110 |
Why?
| | Proteoglycans | 1 | 2010 | 414 | 0.110 |
Why?
| | Child, Preschool | 2 | 2014 | 712 | 0.100 |
Why?
| | Teaching | 1 | 2008 | 60 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2009 | 295 | 0.100 |
Why?
| | Radiotherapy Dosage | 2 | 2018 | 147 | 0.100 |
Why?
| | Recovery of Function | 1 | 2008 | 279 | 0.100 |
Why?
| | Convection | 1 | 2005 | 1 | 0.090 |
Why?
| | Osmosis | 1 | 2005 | 9 | 0.090 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 54 | 0.090 |
Why?
| | Pedigree | 3 | 2010 | 71 | 0.090 |
Why?
| | Aortography | 1 | 2004 | 12 | 0.080 |
Why?
| | Trauma Centers | 1 | 2004 | 9 | 0.080 |
Why?
| | Polymerase Chain Reaction | 3 | 2010 | 204 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 474 | 0.080 |
Why?
| | Kidney Function Tests | 2 | 2013 | 26 | 0.080 |
Why?
| | Lactic Acid | 1 | 2002 | 16 | 0.080 |
Why?
| | Publication Bias | 1 | 2002 | 6 | 0.080 |
Why?
| | Glomerular Filtration Rate | 2 | 2013 | 60 | 0.070 |
Why?
| | Oxygen Consumption | 1 | 2002 | 57 | 0.070 |
Why?
| | Rats | 1 | 2005 | 927 | 0.070 |
Why?
| | Physical Fitness | 1 | 2002 | 50 | 0.070 |
Why?
| | Angiography | 1 | 2002 | 41 | 0.070 |
Why?
| | Heart Rate | 1 | 2002 | 131 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2002 | 357 | 0.070 |
Why?
| | Spinal Cord Diseases | 1 | 2002 | 46 | 0.070 |
Why?
| | Infant, Newborn | 2 | 2014 | 620 | 0.070 |
Why?
| | Malocclusion, Angle Class III | 1 | 2018 | 1 | 0.060 |
Why?
| | Osteotomy, Sagittal Split Ramus | 1 | 2018 | 1 | 0.060 |
Why?
| | Cephalometry | 1 | 2018 | 4 | 0.060 |
Why?
| | Bayes Theorem | 1 | 2017 | 22 | 0.050 |
Why?
| | Leucine | 2 | 2007 | 15 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2018 | 116 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2017 | 17 | 0.050 |
Why?
| | Mutation, Missense | 2 | 2007 | 27 | 0.050 |
Why?
| | Genotype | 2 | 2010 | 384 | 0.050 |
Why?
| | Survival Rate | 1 | 2018 | 386 | 0.050 |
Why?
| | Mice | 2 | 2014 | 1607 | 0.050 |
Why?
| | Osteotomy | 1 | 2018 | 123 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 435 | 0.050 |
Why?
| | Brain | 1 | 2005 | 1194 | 0.050 |
Why?
| | Cerebral Infarction | 1 | 2017 | 142 | 0.050 |
Why?
| | Reperfusion | 1 | 2015 | 11 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2017 | 288 | 0.040 |
Why?
| | Aquaporin 4 | 1 | 2014 | 11 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2014 | 61 | 0.040 |
Why?
| | Thalamic Nuclei | 1 | 2014 | 3 | 0.040 |
Why?
| | Speech Disorders | 1 | 2014 | 13 | 0.040 |
Why?
| | Anhedonia | 1 | 2014 | 4 | 0.040 |
Why?
| | Time Factors | 2 | 2011 | 1620 | 0.040 |
Why?
| | Nerve Degeneration | 1 | 2014 | 47 | 0.040 |
Why?
| | Forecasting | 1 | 2014 | 116 | 0.040 |
Why?
| | Social Perception | 1 | 2014 | 22 | 0.040 |
Why?
| | Disease Management | 1 | 2015 | 110 | 0.040 |
Why?
| | Nerve Net | 1 | 2014 | 40 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2014 | 58 | 0.040 |
Why?
| | Arousal | 1 | 2014 | 61 | 0.040 |
Why?
| | Social Environment | 1 | 2014 | 85 | 0.040 |
Why?
| | Iohexol | 1 | 2013 | 5 | 0.040 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 74 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2014 | 333 | 0.040 |
Why?
| | Attention | 1 | 2014 | 135 | 0.040 |
Why?
| | Radiography, Interventional | 1 | 2013 | 25 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 438 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2014 | 164 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2014 | 375 | 0.040 |
Why?
| | Biopsy | 1 | 2013 | 256 | 0.040 |
Why?
| | Contrast Media | 1 | 2013 | 139 | 0.040 |
Why?
| | Comorbidity | 1 | 2013 | 471 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2011 | 84 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 80 | 0.030 |
Why?
| | Decorin | 1 | 2010 | 18 | 0.030 |
Why?
| | Ultrasonography | 1 | 2011 | 163 | 0.030 |
Why?
| | Haplotypes | 1 | 2010 | 58 | 0.030 |
Why?
| | Registries | 1 | 2011 | 148 | 0.030 |
Why?
| | Middle Cerebral Artery | 1 | 2009 | 18 | 0.030 |
Why?
| | Corneal Edema | 1 | 2009 | 1 | 0.030 |
Why?
| | Endothelium, Corneal | 1 | 2009 | 3 | 0.030 |
Why?
| | Glaucoma | 1 | 2009 | 5 | 0.030 |
Why?
| | Gene Amplification | 1 | 2009 | 27 | 0.030 |
Why?
| | Carotid Arteries | 1 | 2009 | 46 | 0.030 |
Why?
| | Astigmatism | 1 | 2009 | 3 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2014 | 1129 | 0.030 |
Why?
| | Electrophoresis | 1 | 2009 | 23 | 0.030 |
Why?
| | Exons | 1 | 2009 | 43 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2010 | 238 | 0.030 |
Why?
| | Blood Proteins | 1 | 2009 | 22 | 0.030 |
Why?
| | United States | 1 | 2015 | 1960 | 0.030 |
Why?
| | Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 1 | 0.030 |
Why?
| | Cyclin D | 1 | 2008 | 1 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 1021 | 0.030 |
Why?
| | Acute Disease | 1 | 2009 | 253 | 0.030 |
Why?
| | Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 3 | 0.030 |
Why?
| | Cyclins | 1 | 2008 | 6 | 0.030 |
Why?
| | Symporters | 1 | 2008 | 6 | 0.030 |
Why?
| | Genetic Testing | 1 | 2009 | 72 | 0.030 |
Why?
| | Hepatocytes | 1 | 2008 | 11 | 0.030 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 16 | 0.030 |
Why?
| | Ligation | 1 | 2008 | 32 | 0.030 |
Why?
| | Liver Regeneration | 1 | 2008 | 24 | 0.030 |
Why?
| | Dimethylallyltranstransferase | 1 | 2007 | 1 | 0.030 |
Why?
| | Asparagine | 1 | 2007 | 4 | 0.030 |
Why?
| | Valine | 1 | 2007 | 5 | 0.030 |
Why?
| | Serine | 1 | 2007 | 15 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2007 | 11 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2008 | 121 | 0.030 |
Why?
| | Proline | 1 | 2007 | 14 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 40 | 0.030 |
Why?
| | Homozygote | 1 | 2007 | 25 | 0.030 |
Why?
| | Phenotype | 1 | 2009 | 319 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2009 | 137 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2008 | 291 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2008 | 204 | 0.030 |
Why?
| | Up-Regulation | 1 | 2008 | 186 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 261 | 0.030 |
Why?
| | Algorithms | 1 | 2009 | 377 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2013 | 894 | 0.020 |
Why?
| | Cohort Studies | 1 | 2008 | 1512 | 0.020 |
Why?
| | Myelography | 1 | 2002 | 10 | 0.020 |
Why?
| | Arteriosclerosis | 1 | 2002 | 17 | 0.020 |
Why?
| | Aortic Aneurysm | 1 | 2002 | 15 | 0.020 |
Why?
| | Obesity, Morbid | 1 | 2002 | 63 | 0.020 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|